Thymosin Beta-4: Patient Information & Safety Notes
Also known as Tβ4, TMSB4X
Other names: t4, tmsb4x
Thymosin beta-4 is a naturally occurring 43-amino-acid peptide involved in actin regulation, cell migration, and tissue repair. It has been studied in clinical trials for corneal healing and cardiac tissue repair. Systemic use outside approved indications is investigational.
In plain language
What Thymosin Beta-4 is used for
- Studied in research settings for effects on cell migration and tissue-repair pathways
Taking this medicine
How it is administered
- Subcutaneous injection
Read before you decide
Risks and precautions
Risks and warnings
- Injection site irritation
- Headache, nausea, fatigue
Who should not take it
- Personal or family history of cancer (precautionary)
Common questions
Patient questions
Is thymosin beta-4 FDA-approved?
Thymosin beta-4 is not FDA-approved for systemic injection. Clinical research is ongoing. A licensed provider should be consulted for evidence-based wound and tissue recovery options.
Related medications
Explore treatment hubs
This information is educational — not medical advice.
This page is provided for general educational purposes and summarizes publicly available data from sources such as the U.S. Food & Drug Administration. It is not a substitute for the judgment of a licensed clinician and should not be used to start, stop, or change any medication. It may be incomplete or out of date, and individual circumstances vary. Always talk with your prescriber or pharmacist about your specific medications and health conditions. If you think you may have a medical emergency, call 911.
Sources & References
Learn more about where our data comes from and how we write and review medical content.